In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo. Dunn A. Ann Intern Med 2024;177:JC57.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dunn A. In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo. Ann Intern Med 2024;177:JC57.
PMID: 38710082